These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34491462)

  • 1. Cross-reactivity of Haemophilus influenzae type a and b polysaccharides: molecular modeling and conjugate immunogenicity studies.
    Richardson NI; Kuttel MM; Michael FS; Cairns C; Cox AD; Ravenscroft N
    Glycoconj J; 2021 Dec; 38(6):735-746. PubMed ID: 34491462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease.
    Gilsdorf JR
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S321-S330. PubMed ID: 34590133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type b vaccines: history, choice and comparisons.
    Decker MD; Edwards KM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S113-6. PubMed ID: 9781742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
    Fitzwater SP; Ramachandran P; Kahn GD; Nedunchelian K; Suresh S; Santosham M; Chandran A
    Vaccine; 2019 Mar; 37(12):1608-1613. PubMed ID: 30772069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two variants among Haemophilus influenzae serotype b strains with distinct bcs4, hcsA and hcsB genes display differences in expression of the polysaccharide capsule.
    Schouls L; van der Heide H; Witteveen S; Zomer B; van der Ende A; Burger M; Schot C
    BMC Microbiol; 2008 Feb; 8():35. PubMed ID: 18298818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance of Haemophilus influenzae serotypes in Argentina from 2005 to 2010 during the Haemophilus influenzae type b conjugate vaccine era].
    Efron AM; Moscoloni MA; Reijtman VR; Regueira M
    Rev Argent Microbiol; 2013; 45(4):240-7. PubMed ID: 24401777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilus influenzae type b capsular polysaccharide antibody levels in Japanese young patients with hematological malignancies and asplenia.
    Takeshita K; Ishiwada N; Takeuchi N; Takahashi Y; Fukasawa C; Hishiki H; Hoshino T; Shimojo N
    J Infect Chemother; 2020 Sep; 26(9):959-962. PubMed ID: 32402734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries.
    Munson RS; Kabeer MH; Lenoir AA; Granoff DM
    Rev Infect Dis; 1989; 11 Suppl 3():S588-97. PubMed ID: 2669102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children.
    Harrison LH; Tajkowski C; Croll J; Reid R; Hu D; Brenneman G; Weatherholtz RC; Santosham M
    J Pediatr; 1994 Oct; 125(4):571-6. PubMed ID: 7931875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae disease and immunization in developing countries.
    Funkhouser A; Steinhoff MC; Ward J
    Rev Infect Dis; 1991; 13 Suppl 6():S542-54. PubMed ID: 1862284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae: capsule vaccine and capsulation genetics.
    Kroll JS; Booy R
    Mol Med Today; 1996 Apr; 2(4):160-5. PubMed ID: 8796878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children.
    Huska B; Kubinec C; Sadarangani M; Ulanova M;
    Vaccine; 2022 Feb; 40(8):1128-1134. PubMed ID: 35078664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.